Skip to main content
. 2022 Apr 25;9:821317. doi: 10.3389/fcvm.2022.821317

Figure 2.

Figure 2

NEU1 knockdown improved survival rates and cardiac function post-MI. (A) mRNA levels of NEU1 after AAV9-shRNA or AAV9-shNEU1 injection in mice heart (n = 6). (B) NEU1 protein expression and quantitative data (n = 6). (C) Echocardiographic measurements of left ventricular internal diameter at end-systole (LVIDs), left ventricular internal diameter at end-diastole (LVIDd), fractional shortening (FS), ejection fraction (EF), end-diastolic volume (EDV), and end-systolic volume (ESV) in shRNA and shNEU1 hearts after sham operation or 1, 3, 28 and 56 (n = 12 per group) days post-MI. (D) Kaplan–Meier survival analysis of mice after MI (n = 12). *p < 0.05 vs. corresponding group. n.s., non-significant.